Skye Drynan
CIK: 0002015102
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GOSS
Gossamer Bio, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Sep 23, 2026GOSS
Gossamer Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
10K shares- - Jun 4, 2026GOSS
Gossamer Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
115K shares- - Jun 25, 2025GOSS
Gossamer Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
115K shares-
1-3 of 3 transactions
About Drynan Skye
Drynan Skye (SEC CIK 0002015102) files insider reports with the SEC as Director of Gossamer Bio, Inc. (GOSS).
Signal8 holds 3 ownership filings by Drynan Skye, all Form 4s, filed between Jun 26, 2025 and Sep 25, 2026. Those filings report 3 transactions, from Jun 25, 2025 to Sep 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Drynan Skye's filings is in SAN DIEGO, CA.
Recent filings by Drynan Skye
Other insiders filing for Gossamer Bio, Inc. (GOSS)
- Milligan Sandra, Director
- Daniel Thomas O, Director
- Ciongoli Gregory Austin, Director
- Quisel John D, Director
- Cox Russell J., Director
- Nathan Steven D, Director